Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Overhauser-enhanced MR imaging (OMRI)

K Golman1, I Leunbach, J H Ardenkjaer-Larsen

  • 1Nycomed Innovation AB, Malmö, Sweden.

Acta Radiologica (Stockholm, Sweden : 1987)
|March 14, 1998
PubMed
Summary

This study introduces a novel contrast agent designed to improve the quality of magnetic resonance images. By utilizing a specific electron-based substance, the researchers achieved significantly higher signal clarity compared to existing methods. This advancement allows for detailed anatomical and functional imaging at very low magnetic field strengths. The findings suggest that this technology could eventually support routine clinical diagnostic procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Direct measurement of the triple spin flip rate in dynamic nuclear polarization.

Journal of magnetic resonance (San Diego, Calif. : 1997)·2021
Same author

Magnetic resonance imaging with optical preamplification and detection.

Scientific reports·2019
Same author

PIN diode driver for NMR and MRI.

Journal of magnetic resonance (San Diego, Calif. : 1997)·2019
Same author

Hyperpolarized <sup>133</sup>Cs is a sensitive probe for real-time monitoring of biophysical environments.

Chemical communications (Cambridge, England)·2017
Same author

Increased intake of fruits and vegetables in overweight subjects: effects on body weight, body composition, metabolic risk factors and dietary intake.

The British journal of nutrition·2016
Same author

Apparent rate constant mapping using hyperpolarized [1-(13)C]pyruvate.

NMR in biomedicine·2014

Area of Science:

  • Medical imaging physics and Overhauser-enhanced MR imaging research
  • Radiological diagnostic instrumentation development

Background:

No prior work had resolved the limitations of existing contrast agents for low-field magnetic resonance imaging. Current substances provide insufficient signal amplification for practical medical application. This gap motivated the development of a novel electron-based agent. Researchers sought to overcome the low sensitivity inherent in standard imaging techniques. Prior research has shown that signal enhancement is necessary for high-quality diagnostic output. That uncertainty drove the investigation into alternative molecular structures for magnetic resonance. No previous studies had demonstrated such high levels of signal gain in vascular regions. This investigation addresses the urgent need for improved contrast media in clinical settings.

Purpose Of The Study:

The aim of this study was to evaluate a novel single-electron contrast agent for Overhauser-enhanced magnetic resonance imaging. Existing substances currently provide enhancement factors that are too low for routine clinical application. This limitation prevents the technique from becoming a standard diagnostic tool in medical settings. Researchers sought to determine if a new agent could overcome these sensitivity barriers. The investigation focused on achieving higher signal amplification at low magnetic field strengths. This work addresses the need for improved contrast media to enhance image quality. The team intended to demonstrate that functional and morphological data could be obtained simultaneously. This study provides a necessary assessment of the agent's potential for future clinical adoption.

Keywords:
Magnetic Resonance ImagingSignal EnhancementLow-field MRIParamagnetic Agents

Frequently Asked Questions

The researchers propose that the contrast agent achieves a maximum enhancement of 60 times the normal proton signal. This mechanism relies on the interaction between the electron paramagnetic resonance frequency and the magnetic field. Unlike standard agents, this substance provides superior signal-to-noise ratios in vascular areas.

The study utilizes a separate radiofrequency transmitter tuned specifically to the electron paramagnetic resonance frequency of the agent. This hardware component is essential for achieving the observed signal amplification at a low magnetic field of 0.01 Tesla, distinguishing it from conventional clinical scanners.

A low main magnetic field of 0.01 Tesla is necessary to facilitate the Overhauser effect. While standard clinical scanners operate at much higher field strengths, this specific low-field environment allows for the unique interaction between the electron-based agent and the proton signal.

Related Experiment Videos

Main Methods:

Review approach involved evaluating a novel single-electron substance for signal amplification. Investigators injected the agent directly into animal models to assess performance. The team operated the scanner at a main magnetic field of 0.01 Tesla. A separate radiofrequency transmitter was integrated into the system for signal modulation. This hardware was tuned precisely to the electron paramagnetic resonance frequency of the substance. Researchers captured images immediately following the administration of the agent. The experimental design focused on comparing signal quality against established clinical standards. Data collection prioritized the assessment of vascular enhancement and overall image clarity.

Main Results:

Key findings from the literature indicate that the new agent achieved a maximum enhancement of 60 times the normal proton signal. This significant gain occurred specifically within the vascular area of the subjects. The signal-to-noise ratios attained were superior to those reported in previous investigations. These results confirm that the substance effectively boosts signal strength at low magnetic fields. The generated images provided both morphological and functional information simultaneously. Performance metrics showed that the quality was comparable to or better than standard clinical routines. The data demonstrate that the enhancement factors are sufficient for practical imaging applications. These findings highlight the effectiveness of the single-electron approach in low-field environments.

Conclusions:

The authors propose that this novel agent significantly improves signal quality in low-field magnetic resonance imaging. Synthesis and implications suggest that morphological and functional data are now accessible at 0.01 Tesla. The researchers claim that the observed signal-to-noise ratios match or exceed standard clinical benchmarks. This study demonstrates that high enhancement factors are achievable with the new substance. The findings imply that this technology could become a viable option for routine diagnostic use. The authors conclude that the vascular signal gain is particularly notable for future applications. This work provides a foundation for further refinement of electron-based contrast media. The evidence supports the potential for improved diagnostic capabilities in low-field environments.

The researchers used the contrast agent as a functional data source to generate images in rats. This substance acts as a signal enhancer, allowing for the simultaneous collection of morphological and functional information, which is not typically possible with standard agents at such low field strengths.

The measurement focused on the signal-to-noise ratio within the vascular area of the rats. The researchers observed that this ratio was superior to previous attempts, confirming the efficacy of the new agent compared to existing, less effective substances.

The authors propose that this agent makes routine clinical use of low-field imaging a valid possibility. They suggest that the ability to obtain high-quality functional and morphological data at 0.01 Tesla could transform standard diagnostic routines, provided the enhancement factors remain consistent in future applications.